{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:26:20Z","timestamp":1783643180145,"version":"3.55.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T00:00:00Z","timestamp":1468281600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s11060-016-2207-9","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T02:27:20Z","timestamp":1468290440000},"page":"541-544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Utility of MRI versus tumor markers for post-treatment surveillance of marker-positive CNS germ cell tumors"],"prefix":"10.1007","volume":"129","author":[{"given":"Victoria","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devorah","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zagzag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Wisoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias A.","family":"Karajannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,12]]},"reference":[{"issue":"3","key":"2207_CR1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11060-006-9282-2","volume":"82","author":"D Keene","year":"2007","unstructured":"Keene D, Johnston D, Strother D et al (2007) Epidemiological survey of central nervous system germ cell tumors in Canadian children. J Neurooncol 82(3):289\u2013295","journal-title":"J Neurooncol"},{"issue":"1","key":"2207_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11060-013-1306-0","volume":"118","author":"PL Robertson","year":"2014","unstructured":"Robertson PL, Jakacki R, Hukin J, Siffert J, Allen JC (2014) Multimodality therapy for CNS mixed malignant germ cell tumors (MMGCT): results of a phase II multi-institutional study. J Neurooncol 118(1):93\u2013100. doi: 10.1007\/s11060-013-1306-0","journal-title":"J Neurooncol"},{"issue":"5","key":"2207_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/pbc.24888","volume":"61","author":"S Martinez","year":"2014","unstructured":"Martinez S, Khakoo Y, Gilheeney S et al (2014) Marker (+) CNS germ cell tumors in remission: are surveillance MRI scans necessary? Pediatr Blood Cancer 61(5):853\u2013854. doi: 10.1002\/pbc.24888","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2207_CR4","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/pbc.24794","volume":"61","author":"NJ Robison","year":"2014","unstructured":"Robison NJ, Campigotto F, Chi SN et al (2014) A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer. Pediatr Blood Cancer 61(4):636\u2013642. doi: 10.1002\/pbc.24794","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2207_CR5","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.eururo.2005.06.018","volume":"48","author":"A Fl\u00e9chon","year":"2005","unstructured":"Fl\u00e9chon A, Culine S, Th\u00e9odore C, Droz JP (2005) Pattern of relapse after first line treatment of advanced stage germ-cell tumors. Eur Urol 48(6):957\u2013963","journal-title":"Eur Urol"},{"issue":"1","key":"2207_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000292358","volume":"78","author":"K Oechsle","year":"2010","unstructured":"Oechsle K, Lorch A, Honecker F et al (2010) Patterns of relapse after chemotherapy in patients with high-risk non-seminomatous germ cell tumor. Int Soc Cell 78(1):47\u201353. doi: 10.1159\/000292358","journal-title":"Int Soc Cell"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2207-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-016-2207-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2207-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T14:14:28Z","timestamp":1498313668000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-016-2207-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,12]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["2207"],"URL":"https:\/\/doi.org\/10.1007\/s11060-016-2207-9","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,12]]}}}